Health

Tencent has dodged most of China's regulatory crackdown and built an impressive fintech portfolio globally.

In the second part of our look at the year's corporate venturing trends, we analyse fintech and enterprise bull markets along with some emerging regions.

Data storage technology producer Dera pulled in over $150m through a China Unicom-backed series C round while GlobalBees raised in excess of $110m in a round featuring SoftBank and FirstCry.

Multiple corporates have helped staffing software provider Paradox close a $200m series C round, and electronic parts maker BOE Technology is putting up about $47m in a Chinese state-backed vehicle.

The launch of CIV-LAC as a regional corporate entrepreneurial platform is expected to help 600 startups.

Chinese drug discovery platform QureBio raised corporate funding last week while JD.com and Qi-Anxin Technology Group were among the LPs that helped set up the $470m Shoudu Pan Healthcare Industry Fund.

Tencent offers dividend to shareholders through $16.4bn sale of JD.com holding

Drug development platform creator Xbiome has raised nearly $100m in series B funding while bioindustrial startup services provider 21st.Bio secured a similar amount from Novo.

Cambridge spinout Gyroscope, which counts Fosun as an investor, is set to be picked up for a healthy premium on the projected valuation at which it failed to float in May.

Corporate-backed unicorns Via and Cohesity have both confidentially filed to go public while autonomous driving technology developer Haomo.AI raised nearly $157m.

Mobile wallet developer Momo grabbed $200m in a Mizuho Bank-led round valuing it above $2bn while silicon wafer producer Mieke pulled in $188m.